acyclovir NDC 50090-3250

Product information

Brand name (proprietary)

acyclovir

Generic name (nonproprietary)

acyclovir

Active ingredients

Acyclovir — 400 mg/1

Dosage form

Tablet

Route

Oral

Labeler

A-S Medication Solutions

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 204314

Marketing start

Sep 10, 2014

Listing expires

Dec 31, 2026

Other FDA classes

DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)

Identifiers

Product ID 50090-3250_0c61c8ca-1f35-4ffa-b0a1-888b08f47f5fSPL ID 0c61c8ca-1f35-4ffa-b0a1-888b08f47f5fSPL set ID c40a57b9-4cf1-4a69-abf3-eb99a7fcda00RxCUI 197311UNII X4HES1O11F

Pharmacologic class

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090325000 followed by a unit qualifier and the quantity Copy

Package 50090-3250-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 204314

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.